Vorinostat Completed Phase 1 / 2 Trials for Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma / Contiguous Stage II Mantle Cell Lymphoma / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Stage I Mycosis Fungoides/Sezary Syndrome / Anaplastic Large Cell Lymphoma / Stage III Mycosis Fungoides/Sezary Syndrome / Angioimmunoblastic T-Cell Lymphoma / Splenic Marginal Zone Lymphoma / Recurrent Grade 3 Follicular Lymphoma / Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue / Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Adult Immunoblastic Large Cell Lymphoma / Noncontiguous Stage II Mantle Cell Lymphoma / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Stage II Mycosis Fungoides/Sezary Syndrome / Recurrent Small Lymphocytic Lymphoma / Cutaneous B-Cell Non-Hodgkin Lymphoma / Stage I Cutaneous T-cell Non-Hodgkin Lymphoma / Recurrent Marginal Zone Lymphoma / Recurrent Adult Hodgkin's Lymphoma / Adult Nasal Type Extranodal NK/T-Cell Lymphoma / Stage IV Mycosis Fungoides/Sezary Syndrome / Recurrent Adult Lymphoblastic Lymphoma / Waldenström's Macroglobulinemia (WM) / Recurrent Adult Burkitt Lymphoma / Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Stage III Mantle Cell Lymphoma / Recurrent Mycosis Fungoides/Sezary Syndrome / Stage II Cutaneous T-cell Non-Hodgkin Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Stage I Mantle Cell Lymphoma / Recurrent Adult Diffuse Mixed Cell Lymphoma / Nodal marginal zone B-cell lymphomas / Recurrent Grade 2 Follicular Lymphoma / Stage IV Mantle Cell Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs